文献速递传染病防控与疫情报告免疫规划

靶向OMPL1、LipL32、LipL41和LipL46的多表位钩端螺旋体疫苗的免疫信息学设计与ICR雄鼠体内评价

Immunoinformatics design and in vivo evaluation of a multiepitope vaccine targeting OMPL1, Lipl32, Lipl41, and Lipl46 for leptospirosis in a male ICR mouse model.
PubMed 文献 · Vaccine · 2026-02-10

本研究基于8种致病性钩端螺旋体保守表位设计多表位疫苗,经免疫信息学筛选出构建体4(LH),并以DNA疫苗(pVAX1)和蛋白疫苗(pET30a)形式在ICR雄鼠中肌内接种。两种疫苗均诱导显著升高的血清IgG,蛋白疫苗显著刺激产生IFN-γ的T细胞,显微凝集试验确认了针对钩端螺旋体血清型的中和抗体应答。

要点

  • 多表位疫苗LH涵盖OMPL1、LipL32、LipL41和LipL46的保守表位,可激活B细胞、CD4+和CD8+细胞。
  • DNA与蛋白疫苗加铝佐剂肌内接种ICR雄鼠后14–42天血清IgG显著升高。
  • 蛋白疫苗显著刺激IFN-γ产生T细胞,显微凝集试验确认中和抗体应答。

核心结论

  • 含四种外膜蛋白表位的多表位DNA和蛋白疫苗能在ICR雄鼠中诱导强免疫应答,为后续攻毒保护研究提供依据。

研究设计与样本

  • 基于8种钩端螺旋体菌种OMPL1、LipL32、LipL41和LipL46的保守表位设计多表位疫苗,用免疫信息学工具分析6个构建体。
  • 构建体4(LH)基因克隆入pVAX1载体作DNA疫苗、克隆入pET30a载体表达蛋白疫苗,加铝佐剂肌内接种ICR雄鼠。

主要发现

  • 接种后14至42天ELISA检测显示两种疫苗均显著升高血清IgG水平。
  • 流式细胞术显示蛋白疫苗显著刺激IFN-γ产生T细胞,提示CD4+和CD8+ T细胞致敏。
  • 显微凝集试验确认疫苗诱导针对钩端螺旋体血清型的中和抗体应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Leptospirosis is the most widespread and under-recognized zoonotic disease with around 1.03 million cases and ∼ 60,000 reported fatalities occurring each year. It is a threat to humans as well as animals and can only be avoided by appropriate immunization. In this study, epitopes from proteins present on the exterior membrane of selected pathogenic Leptospira species were used as immunogens viz. OMPL1, LipL32, LipL41 and LipL46. Conserved epitopes from each of the proteins across 8 species of Leptospira were screened and used to generate a multi-epitope vaccine that activates B cells, CD4+ and CD8+ cells. Six vaccine constructs were analyzed employing various immunoinformatics tools for physicochemical properties, structure prediction followed by validation, docking with immune receptors and molecular dynamics simulation. The vaccine construct 4 (LH) was found to comply with all the desired parameters to further consider for in vivo efficacy evaluation. For in vivo validation, gene for LH was cloned in a pVAX1 vector to be used as a DNA vaccine and in pET30a vector to express protein vaccine. DNA and protein vaccines were administered intramuscularly in ICR male mice along with adjuvant alhydrogel. Both types of vaccines elicited strong immune response evidenced from significantly increased serum IgG level evaluated by ELISA post the duration of 14 to 42 days. IFN-γ cytokine producing T cells were significantly stimulated in protein vaccine as revealed by flow cytometry suggesting the priming of CD4+ and CD8+ T cells by vaccine. The neutralizing antibody response to Leptospira serovars was confirmed with microscopic agglutination test. In summary, this study illustrates the prospective of multi-epitope DNA and protein vaccines incorporating epitopes from four outer membrane proteins to generate a strong immune response, paving the way forward for protection during challenge study against virulent Leptospira pathogens in animal model.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Thumar R, Shekh SL, Chauhan A, et al. Immunoinformatics design and in vivo evaluation of a multiepitope vaccine targeting OMPL1, Lipl32, Lipl41, and Lipl46 for leptospirosis in a male ICR mouse model. Vaccine. 2026. PMID: 41672031. doi:10.1016/j.vaccine.2026.128331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。